Frontlight ResearchEarly access
WithdrawnNo phase
Precision Ablation For Pulmonary Vein Isolation: Targeting Pulmonary Vein Myocardial Sleeves (PVMS) With Omnipolar Mapping Technology
Key facts
- Who runs it
- The University of Texas Health Science Center, Houston
- Where
- Houston, United StatesSee the site
- Trial code
- Status
- Withdrawn
- Started
- 15 Jan 2025
- Ended
- 31 Oct 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- PVS-PVI targeted ablation
- Wide area circumferential ablation (WACA)
- Record updated
- 28 January 2026
- Why it stopped
- lack of recruitment after technological advances replaced the study procedure.
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Symptomatic paroxysmal AF refractory to at least one Class I or Class III antiarrhythmic medication, intolerance to antiarrhythmic medications, or a preference to not trial antiarrhythmic medications
- A minimum of one documented AF episode via 12-lead ECG, Holter monitor, or loop recorder
- Capability to provide informed consent
Who cannot take part
- Prior history of catheter or surgical ablation for AF or left atrial ablation for atypical flutter
- Congenital heart disease
- Significant valve disease (moderate or severe mitral/aortic stenosis or regurgitation)
- Systemic oral anticoagulation therapy contraindicated, including a history of heparin-induced thrombocytopenia
- Persistent or permanent AF
- Reversible causes of AF
- Pregnancy
- Known presence of intracardiac thrombus
- Broad vortex-like connections and no clear PVMS to be targeted
Where in United States
- The University of Texas Health Science Center at HoustonHouston, United States
About the trial
What the trial wants to find out
The purpose of this study is to compare procedural times and Radiofrequency (RF)applications required for Pulmonary vein myocardial sleeves targeted pulmonary vein ablation (PVS-PVI) , to compare the efficacy of PVS-PVI , to compare the safety of PVS-PVI and to assess other clinical outcomes of PVS-PVI in individuals with symptomatic paroxysmal Atrial fibrillation (AF) using Omnipolar Technology with conventional Wide area circumferential ablation (WACA).
The 2 groups in the trial
- PVS-PVITreatment being tested
Treatment: PVS-PVI targeted ablation
- WACAExisting treatment, for comparison
Treatment: Wide area circumferential ablation (WACA)
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Precision Ablation For Pulmonary Vein Isolation: Targeting Pulmonary Vein Myocardial Sleeves With Omnipolar Mapping Technology - A Randomized Pilot Trial
- Record updated
- 28 January 2026